Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c862 |
|---|---|
| Identifier | NCT05466890 |
| Trial Title | Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Ulcerative Colitis Acute|Ulcerative|Ulcerative Colitis Flare |
| Interventions | DRUG: PL8177 Placebo|DRUG: PL8177 |
Participant Information
| Sponsor | Palatin Technologies, Inc |
|---|---|
| City | Tucson |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-09-15 |
|---|---|
| Primary Completion Date | 2025-02-10 |
| Completion Date | 2025-03-31 |